To test this hypothesis, we adopted gene-silencing approach where we transiently transfected MDA-MB-231 breast cancer cells and HMEC with either a control or Pfn1-specific siRNA, and examined the changes in cell motility. Here, PFN1 is linked to breast carcinoma.